AI Summary
This title suggests that starting treatment with inclisiran earlier may lead to better long-term reductions in LDL cholesterol levels. The VICTORION-INITIATE study's results indicate superior outcomes with inclisiran as an initial treatment option and shed light on the inadequate management of cholesterol in patients with cardiovascular disease in current clinical practice. The term "stunning undertreatment" emphasizes the need for improved care for individuals with CVD.
Results of VICTORION-INITIATE study suggest better results with inclisiran first and highlight “stunning undertreatment” of cholesterol in usual care of patients with CVD.
Medscape Medical News